Cargando…

Risk Factors of Venous Thromboembolism in Patients With Lung Cancer Before Surgery: A Case Control Study

OBJECTIVE: This study aimed to investigate the risk factors of venous thromboembolism (VTE) in admitted patients with lung carcinoma before surgery. METHODS: We conducted a retrospective case-control study of 94 preoperative lung cancer patients with VTE between January 2017 to December 2020. Each V...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fangyuan, Liu, Lifeng, Sha, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561671/
https://www.ncbi.nlm.nih.gov/pubmed/36223407
http://dx.doi.org/10.1177/10732748221127826
_version_ 1784807998830411776
author Zhang, Fangyuan
Liu, Lifeng
Sha, Yongsheng
author_facet Zhang, Fangyuan
Liu, Lifeng
Sha, Yongsheng
author_sort Zhang, Fangyuan
collection PubMed
description OBJECTIVE: This study aimed to investigate the risk factors of venous thromboembolism (VTE) in admitted patients with lung carcinoma before surgery. METHODS: We conducted a retrospective case-control study of 94 preoperative lung cancer patients with VTE between January 2017 to December 2020. Each VTE patients was randomly matched with 2 control patients according to residence and gender. The clinical characteristics and related laboratory test results between the groups were compared by univariate analysis, while the risk factors of VTE in preoperative patients with lung cancer were analyzed using multivariate logistic regression analysis. RESULTS: Patients aged ≥60 years, a history of arrhythmia, homocysteine>15ummol/L, Fibrinogen (FIB) >4 g/L and D-dimer>500 ng/mL were found to be associated with an increased risk of VTE by univariate analysis. The multivariate logistic regression analysis revealed that age ≥60 years (OR=10.985), FIB >4 g/L (OR=8.861) and D-Dimer >500 ng/mL (OR=6.613) were independent risk factors for VTE in patients with lung carcinoma before surgery (P<.05). CONCLUSION: For preoperative patients with lung cancer, the independent risk factors of VTE included age ≥60 years, FIB >4 g/L and D-Dimer >500 ng/mL. As for these patients, prophylactic anticoagulant therapy should be considered before surgery.
format Online
Article
Text
id pubmed-9561671
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-95616712022-10-15 Risk Factors of Venous Thromboembolism in Patients With Lung Cancer Before Surgery: A Case Control Study Zhang, Fangyuan Liu, Lifeng Sha, Yongsheng Cancer Control Original Research Article OBJECTIVE: This study aimed to investigate the risk factors of venous thromboembolism (VTE) in admitted patients with lung carcinoma before surgery. METHODS: We conducted a retrospective case-control study of 94 preoperative lung cancer patients with VTE between January 2017 to December 2020. Each VTE patients was randomly matched with 2 control patients according to residence and gender. The clinical characteristics and related laboratory test results between the groups were compared by univariate analysis, while the risk factors of VTE in preoperative patients with lung cancer were analyzed using multivariate logistic regression analysis. RESULTS: Patients aged ≥60 years, a history of arrhythmia, homocysteine>15ummol/L, Fibrinogen (FIB) >4 g/L and D-dimer>500 ng/mL were found to be associated with an increased risk of VTE by univariate analysis. The multivariate logistic regression analysis revealed that age ≥60 years (OR=10.985), FIB >4 g/L (OR=8.861) and D-Dimer >500 ng/mL (OR=6.613) were independent risk factors for VTE in patients with lung carcinoma before surgery (P<.05). CONCLUSION: For preoperative patients with lung cancer, the independent risk factors of VTE included age ≥60 years, FIB >4 g/L and D-Dimer >500 ng/mL. As for these patients, prophylactic anticoagulant therapy should be considered before surgery. SAGE Publications 2022-10-12 /pmc/articles/PMC9561671/ /pubmed/36223407 http://dx.doi.org/10.1177/10732748221127826 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Zhang, Fangyuan
Liu, Lifeng
Sha, Yongsheng
Risk Factors of Venous Thromboembolism in Patients With Lung Cancer Before Surgery: A Case Control Study
title Risk Factors of Venous Thromboembolism in Patients With Lung Cancer Before Surgery: A Case Control Study
title_full Risk Factors of Venous Thromboembolism in Patients With Lung Cancer Before Surgery: A Case Control Study
title_fullStr Risk Factors of Venous Thromboembolism in Patients With Lung Cancer Before Surgery: A Case Control Study
title_full_unstemmed Risk Factors of Venous Thromboembolism in Patients With Lung Cancer Before Surgery: A Case Control Study
title_short Risk Factors of Venous Thromboembolism in Patients With Lung Cancer Before Surgery: A Case Control Study
title_sort risk factors of venous thromboembolism in patients with lung cancer before surgery: a case control study
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561671/
https://www.ncbi.nlm.nih.gov/pubmed/36223407
http://dx.doi.org/10.1177/10732748221127826
work_keys_str_mv AT zhangfangyuan riskfactorsofvenousthromboembolisminpatientswithlungcancerbeforesurgeryacasecontrolstudy
AT liulifeng riskfactorsofvenousthromboembolisminpatientswithlungcancerbeforesurgeryacasecontrolstudy
AT shayongsheng riskfactorsofvenousthromboembolisminpatientswithlungcancerbeforesurgeryacasecontrolstudy